India says Johnson and Johnson pulls out proposal for quick COVID-19 vaccine approval Kumar Jeetendra | August 2, 2021 India’s drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the …
Pharmaceutical Roots – Almonds and Enantiomers Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Mandelic acid Mandelic acid is a small, aromatic compound with many different uses. Although these days it is usually prepared in the lab, mandelic …
Pharmaceutical Roots – The origins of opioids Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new content series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and Morphine is a type of opiate pain medication with a strong analgesic duration, lasting from three to seven hours. Named after Morpheus, the Greek god of …
Roche launches spinal muscular atrophy treatment drug in India evaluated at around Rs 6 lakh per bottle Kumar Jeetendra | July 30, 2021 Pharma major Roche on Thursday said it has launched prescription medicine Evrysdi in India, which is used for treatment of spinal muscular atrophy (SMA) in adults, children aged 2 months and older, at a maximum retail price of around Rs 6 lakh per bottle. Evrysdi was first approved by the United States Food and Drug …
Pfizer and AstraZeneca vaccine antibody levels might decrease following 2-3 months: Lancet study Kumar Jeetendra | July 27, 2021 Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal. The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping …
Sun Pharma, Cassiopea SpA ink permit and supply arrangements for acne treatment drug Winlevi Kumar Jeetendra | July 26, 2021 New Delhi, Jul 26 (PTI) Drug major Sun Pharma on Monday said it has signed license and supply agreements with Cassiopea SpA for acne treatment drug Winlevi in the US and Canada. Sun Pharmaceutical Industries and Cassiopea SpA on Monday announced the signing of license and supply agreements for Winlevi (clascoterone cream 1 per cent) …
BDR Pharma inks permit concurrence with DRDO to deliver COVID-19 drug 2-DG Kumar Jeetendra | July 26, 2021 BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country. BDR Pharma has inked a pact with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) …
FDC introduced Favipiravir oral suspension to treat COVID-19 in India Kumar Jeetendra | July 12, 2021 Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement. Convenient loading dosage of the oral suspension …
Alembic Pharma gets USFDA endorsement for anti-depressant drug Kumar Jeetendra | July 8, 2021 Drug firm Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator for Desipramine Hydrochloride tablets used in the treatment of depression. The approved product is therapeutically equivalent to the reference listed drug product Norpramin tablets of Validus Pharmaceuticals LLC. The company has received approval from the US Food and Drug …
Pfizer, Moderna vaccines cut COVID-19 danger by 91%: Study Kumar Jeetendra | July 8, 2021 People who receive COVID-19 vaccines by Pfizer and Moderna are up to 91 per cent less likely to develop the disease, according to a US study which also suggests that the preventives reduce the severity of symptoms and duration in those who still get an infection. The research, published in the New England Journal of …
Israel to send 700,000 Pfizer dosages to South Korea in trade bargain Kumar Jeetendra | July 6, 2021 Israel is sending 700,000 coronavirus vaccine doses to South Korea in exchange for a future shipment of the jabs, Prime Minister Naftali Bennett said Tuesday. In a statement, Bennett said Israel will transfer the Pfizer vaccines to South Korea in an effort to inoculate more of the Asian nation’s citizens this month. South Korea will …
Optima Laboratory Resource Management System V2021.1 Software Release Announcement Kumar Jeetendra | July 2, 2021 Madrid, Spain – 01 July 2021 – – We are delighted to announce the new Optima Laboratory Resource Management System – LRMS version 2021.1. released by July 1st, 2021. It is a major milestone incorporating a sophisticated engine that automates the complex scheduling process of the laboratory resources. Optima’s algorithm combines all information collected in …
